Nanostructured lipid carriers system: Recent advances in drug delivery

References

• Anton N, Benoit JP, Saulnier P. (2008). Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release, 128, 185–199.
   PubMed Web of Science ®Google Scholar
• Benson HA, Sarveiya V, Risk S, Roberts MS. (2005). Influence of anatomical site and topical formulation on skin penetration of sunscreens. Ther Clin Risk Manag, 1, 209–218.
   PubMedGoogle Scholar
• Bilska A, Wlodek L. (2005). Lipoic acid - the drug of the future? Pharmacol Rep, 57, 570–577.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Westsen K, Koch MHJ. (1996). Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 129, 159–173.
   Web of Science ®Google Scholar
• Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. (2002). Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm, 238, 241–245.
   PubMed Web of Science ®Google Scholar
• Chen CC, Tsai TH, Huang ZR, Fang JY. (2010). Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm, 74, 474–482.
   PubMed Web of Science ®Google Scholar
• Chan J, Maghraby GM, Craig JP, Alany RG. (2007). Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation. Int J Pharm, 328, 65–71.
   PubMed Web of Science ®Google Scholar
• Charcosset C, El-Harati A, Fessi H. (2005). Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release, 108, 112–120.
   PubMed Web of Science ®Google Scholar
• Charman WN. (2000). Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. J Pharm Sci, 89, 967–978.
   PubMed Web of Science ®Google Scholar
• Charman WN, Porter CJ, Mithani S, Dressman JB. (1997). Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci, 86, 269–282.
   PubMed Web of Science ®Google Scholar
• Cirri M, Bragagni M, Mennini N, Mura P. (2012). Development of a new delivery system consisting in “drug–in cyclodextrin–in nanostructured lipid carriers” for ketoprofen topical delivery. Eur J Pharm Biopharm, 80, 46–53.
   PubMed Web of Science ®Google Scholar
• Cook N, Freeman S. (2001). Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the Skin and Cancer Foundation. Australas J Dermatol, 42, 257–259.
   PubMedGoogle Scholar
• Covino BG, Vassallo HG. (1976). Local anesthetics: mechanisms of action and clinical use. 1st ed. (Grune & Stratton: New York) 123–148.
   Google Scholar
• Das S, Chaudhury A. (2011). Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech, 12, 62–76.
   PubMed Web of Science ®Google Scholar
• Davidson MH, Lukacsko P, Sun JX, Phillips G, Walters E, Sterman A, Niecestro R, Friedhoff L. (2002). A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin. Clin Ther, 24, 112–125.
   PubMed Web of Science ®Google Scholar
• Doktorovová S, Araújo J, Garcia ML, Rakovský E, Souto EB. (2010). Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B Biointerfaces, 75, 538–542.
   PubMed Web of Science ®Google Scholar
• Eitenmiller RR, Landen Jr, WO. (1998). Vitamin analysis for the health and food sciences (Woodhead Publishing: Cambridge, UK).
   Google Scholar
• Estella-Hermoso de Mendoza A, Campanero MA, Mollinedo F, Blanco-Prieto MJ. (2009). Lipid nanomedicines for anticancer drug therapy. J Biomed Nanotechnol, 5, 323–543.
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. (2008). Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm, 70, 633–640.
   PubMed Web of Science ®Google Scholar
• Foye WO, Lemke TL, Williams DA. (2007). Foye’s principles of medicinal chemistry, 6th ed. (Philadelphia, PA: Lippincott Williams & Wilkins).
   Google Scholar
• Freitas C, Muller RH. (1998). Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN (TM)) dispersions. Int J Pharm, 168, 221–229.
   Web of Science ®Google Scholar
• Gasco MR. (1993). Method for producing solid lipid microspheres having a narrow size distribution US Patent 5 250 236.
   Google Scholar
• Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. (2004). PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm, 57, 207–212.
   PubMed Web of Science ®Google Scholar
• Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. (1995). Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol, 13, 996–1003.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Miraa E, Egeaa MA, Garciaa M, Souto EB. (2010). Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces, 81, 412–421.
   PubMed Web of Science ®Google Scholar
• Hagedorn-Leweke U, Lippold BC. (1998). Accumulation of sunscreens and other compounds in keratinous substrates. Eur J Pharm Biopharm, 46, 215–221.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. (2002). A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res, 19, 875–880.
   PubMed Web of Science ®Google Scholar
• Huang ZR, Hua SC, Yang YL, Fang JY. (2008). Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin, 29, 1094–1102.
   PubMed Web of Science ®Google Scholar
• Hung LC, Basri M, Tejo BA, Ismail R, Nang HL, Abu Hassan H, May CY. (2011). An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Colloids Surf B Biointerfaces, 87, 180–186.
   PubMed Web of Science ®Google Scholar
• Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, Baner K, Benet LZ, Sewing KF, Christians U. (1999). Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin. J Pharmacol Exp Ther, 291, 131–139.
   PubMed Web of Science ®Google Scholar
• Jain NK, Ram A. (2011). Development and characterization of nanostructured lipid carriers of oral hypoglycemic agent selection of surfactants. Int J Pharm Sci Rev Res 7, 125–130.
   Google Scholar
• Jaques PA, Kim CS. (2000). Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol, 12, 715–731.
   PubMed Web of Science ®Google Scholar
• Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, Wang F, Liu Y, Zhang Q. (2010). Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Colloids Surf B Biointerfaces, 80, 213–218.
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. (2008). Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm, 346, 124–132.
   PubMed Web of Science ®Google Scholar
• Kakkar V, Singh S, Singla D, Kaur IP. (2011). Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res, 55, 495–503.
   PubMed Web of Science ®Google Scholar
• Köhn FM, Schill WB. (2003). A new oral testosterone undecanoate formulation. World J Urol, 21, 311–315.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. (2007). Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm, 335, 167–175.
   PubMed Web of Science ®Google Scholar
• Lauweryns JM, Baert JH. (1977). Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir Dis, 115, 625–683.
   PubMed Web of Science ®Google Scholar
• Leonard M. (1998). Carl Koller: mankind’s greatest benefactor? The story of local anesthesia. J Dent Res, 77, 535–538.
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W. (2009). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm, 379, 131–138.
   PubMed Web of Science ®Google Scholar
• Liedtke S, Zimmermann E, Muller RH, Mader K. (1999). Physical characterisation of solid lipid nanoparticles (SLN). Proc Int Symp Control Release Bioact Mater, 26, 595–596.
   Google Scholar
• Lin YK, Huang ZR, Zhuo RZ, Fang JY. (2010). Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine, 5, 117–128.
   PubMed Web of Science ®Google Scholar
• Lipinski C. (2002). Poor aqueous solubility: an industry wide problem in drug discovery. Am Pharm Rev 5, 82–85.
   Google Scholar
• Liu CH, Wu CT. (2010). Optimization of nanostructured lipid carriers for lutein delivery. Colloids Surf B Biointerfaces, 353, 149–156.
   Web of Science ®Google Scholar
• Liu DH, Liu CX, Zou WW, Zhang N. (2010). Enhanced gastrointestinal absorption of N-3-O-toluyl-fluorouracil by cationic solid lipid nanoparticles. J Nanopart Res, 12, 975–984.
   Web of Science ®Google Scholar
• Liu D, Liu Z, Wang L, Zhang C, Zhang N. (2011). Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces, 85, 262–269.
   PubMed Web of Science ®Google Scholar
• Madishetti SK, Palem CR, Gannu R, Thatipamula RP, Panakanti PK, Yamsani MR. (2010). Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization. Daru, 18, 221–229.
   PubMed Web of Science ®Google Scholar
• Marquele-Oliveiraa F, de Almeida Santanaa DC, Taveiraa SF, Vermeulena DM, de Oliveirab ARM, da Silva RS, Lopeza RFV. (2010). Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation. J Pharm Biomed Anal, 53, 843–851.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev, 47, 165–196.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Müller RH, Keck CM. (2011). Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement. Drug Dev Ind Pharm, 37, 8–14.
   PubMed Web of Science ®Google Scholar
• Muller RH, Dingler A. (1998). The next generation after the liposomes: solid lipid nano particles (SLN®, LipopearlsTM) as dermal carrier in cosmetics. Eurocosmetics. 8, 19–26.
   Google Scholar
• Muller RH, Lucks JS. (1996). Arzneistoffträger aus festen Lipidteilchen - Feste Lipid Nanosphären (SLN). European Patent 0605497.
   Google Scholar
• Müller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm, 50, 161–177.
   PubMed Web of Science ®Google Scholar
• Müller RH, Petersen RD, Hommoss A, Pardeike J. (2007). Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev, 59, 522–530.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 54 Suppl 1, S131–S155.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm, 242, 121–128.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 54 Suppl 1, S131–S155.
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge SA, Ravelli V, Thünemann AF, Mehnert W, Souto EB. (2008). Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm, 68, 535–544.
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge S, Ravelli V, Mehnert W, Thünemann AF, Souto EB. (2006). Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm, 317, 82–89.
   PubMed Web of Science ®Google Scholar
• Müller RH, Shegokar R, Keck CM. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol, 8, 207–227.
   PubMedGoogle Scholar
• Nakai Y, Yamamoto K, Terada K, Akimoto K. (1984). The dispersed states of medicinal molecules in ground mixtures with α- or β-cyclodextrin. Chem Pharm Bull, 32, 685–690.
   Web of Science ®Google Scholar
• Obeidat WM, Schwabe K, Müller RH, Keck CM. (2010). Preservation of nanostructured lipid carriers (NLC). Eur J Pharm Biopharm, 76, 56–67.
   PubMed Web of Science ®Google Scholar
• Ogretmen B, Safa AR. (1999). Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.. Biochemistry, 38, 2189–2199.
   PubMed Web of Science ®Google Scholar
• Packer L. (1998). alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury. Drug Metab Rev, 30, 245–275.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP. (2009). Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine, 5, 184–191.
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller GK. (2005). Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis (Edinb), 85, 227–234.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 366, 170–184.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Weber S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A. (2011). Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm, 419, 329–338.
   PubMed Web of Science ®Google Scholar
• Patel M, Jain SK, Yadav AK, Gogna D, Agrawal GP. (2006). Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy. Drug Deliv, 13, 323–330.
   PubMed Web of Science ®Google Scholar
• Pathak P, Nagarsenker M. (2009). Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech, 10, 985–992.
   PubMed Web of Science ®Google Scholar
• Patlolla RR, Chougule M, Patel AR, Jackson T, Tata PN, Singh M. (2010). Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release, 144, 233–241.
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. (2011). Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Eur J Pharm Biopharm, 79, 82–94.
   PubMed Web of Science ®Google Scholar
• Puglia C, Sarpietro MG, Bonina F, Castelli F, Zammataro M, Chiechio S. (2011). Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers. J Pharm Sci, 100, 1892–1899.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A. (2007). Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev, 59, 411–418.
   PubMed Web of Science ®Google Scholar
• Radtke M. (2001). Pure drug nanoparticles for the formulation of poorly soluble drugs. New Drugs 3, 62–68.
   Google Scholar
• Ricci M, Puglia C, Bonina F, Di Giovanni C, Giovagnoli S, Rossi C. (2005). Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci, 94, 1149–1159.
   PubMed Web of Science ®Google Scholar
• Ruktanonchai U, Bejrapha P, Sakulkhu U, Opanasopit P, Bunyapraphatsara N, Junyaprasert V, Puttipipatkhachorn S. (2009). Physiochemical Characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic Acid. AAPS PharmSciTech, 10, 227–234.
   PubMed Web of Science ®Google Scholar
• Ruktanonchai U, Bejrapha P, Sakulkhu U, Opanasopit P, Bunyapraphatsara N, Junyaprasert V, Puttipipatkhachorn S. (2009). Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. AAPS PharmSciTech, 10, 227–234.
   PubMed Web of Science ®Google Scholar
• Sahana B, Santra K, Basu S, Mukherjee B. (2010). Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation. Int J Nanomedicine, 5, 621–630.
   PubMed Web of Science ®Google Scholar
• Sanad RA, Abdelmalak NS, Elbayoomy TS, Badawi AA. (2010). Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). AAPS PharmSciTech, 11, 1684–1694.
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, Alka A. (2009). Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target, 17, 249–256.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Müller-Goymann CC. (2003). Solvent injection as a new approach for manufacturing lipid nanoparticles–evaluation of the method and process parameters. Eur J Pharm Biopharm, 55, 125–131.
   PubMed Web of Science ®Google Scholar
• Shahgaldian P, Da Silva E, Coleman AW, Rather B, Zaworotko MJ. (2003). Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int J Pharm, 253, 23–38.
   PubMed Web of Science ®Google Scholar
• Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. (2008). Solid lipid nanoparticles and nanostructured lipid carriers–innovative generations of solid lipid carriers. Curr Drug Deliv, 5, 324–331.
   PubMedGoogle Scholar
• Silva AC, Santos D, Ferreira DC, Souto EB. (2009). Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie, 64, 177–182.
   PubMed Web of Science ®Google Scholar
• Sjöström B, Bergenståhl B. (1992). Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm 88, 53–62.
   Web of Science ®Google Scholar
• Smith DW, Peterson MR, DeBerard SC. (1999). Local anesthesia. Topical application, local infiltration, and field block. Postgrad Med, 106, 57–60, 64.
   PubMed Web of Science ®Google Scholar
• Souto EB. (2005). SLN and NLC for Topical Delivery of Antifungals. Ph.D. Thesis. Institute of Pharmacy, Free University of Berlin, Germany.
   Google Scholar
• Souto EB, Müller RH. (2006). The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie, 61, 431–437.
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. (2007). Nanoparticulate drug delivery systems. Thassu D, Deleers M, Pathak Y (eds) vol. 166 (New York, London: Informa Healthcare) 213–233.
   Google Scholar
• Souto EB, Almeida AJ, Muller RH. (2007). Lipid Nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol, 3, 317–331.
   Web of Science ®Google Scholar
• Souto EB, Mehnert W, Müller RH. (2006). Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J Microencapsul, 23, 417–433.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm, 278, 71–77.
   PubMed Web of Science ®Google Scholar
• Souza LG, Silva EJ, Martins AL, Mota MF, Braga RC, Lima EM, Valadares MC, Taveira SF, Marreto RN. (2011). Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm, 79, 189–196.
   PubMed Web of Science ®Google Scholar
• Stecová J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, Seltmann H, Korting HC, Kramer KD, Schäfer-Korting M. (2007). Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res, 24, 991–1000.
   PubMed Web of Science ®Google Scholar
• Sweetman SC. (2007). Matrindale the complete drug reference (Pharmaceutucal press London, UK) 1556–1557.
   Google Scholar
• Teeranachaideekul V, Müller RH, Junyaprasert VB. (2007). Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)–effects of formulation parameters on physicochemical stability. Int J Pharm, 340, 198–206.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. (2007). Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm, 67, 141–148.
   PubMed Web of Science ®Google Scholar
• Thatipamula R, Palem C, Gannu R, Mudragada S, Yamsani M. (2011). Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. Daru, 19, 23–32.
   PubMed Web of Science ®Google Scholar
• Trotta M, Debernardi F, Caputo O. (2003). Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm, 257, 153–160.
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Huang YB, Wu PC, Fu YS, Kao YR, Fang JY, Tsai YH. (2011). Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J Pharm Sci, 100, 547–557.
   PubMed Web of Science ®Google Scholar
• Uner M, Yener G. (2007). Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine, 2, 289–300.
   PubMed Web of Science ®Google Scholar
• Wollin SD, Jones PJ. (2003). Alpha-lipoic acid and cardiovascular disease. J Nutr, 133, 3327–3330.
   PubMed Web of Science ®Google Scholar
• Xie S, Pan B, Wang M, Zhu L, Wang F, Dong Z, Wang X, Zhou W. (2010). Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles. Nanomedicine (Lond), 5, 693–701.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nishioka K. (2003). Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol, 13, 471–473.
   PubMed Web of Science ®Google Scholar
• Yuan H, Wang LL, Du YZ, You J, Hu FQ, Zeng S. (2007). Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf B Biointerfaces, 60, 174–179.
   PubMed Web of Science ®Google Scholar
• Zauner W, Farrow NA, Haines AM. (2001). In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release, 71, 39–51.
   PubMed Web of Science ®Google Scholar
• Zhai H, Maibach HI. (2001). Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol, 14, 1–10.
   PubMedGoogle Scholar
• Zhang J, Fan Y, Smith E. (2009). Experimental design for the optimization of lipid nanoparticles. J Pharm Sci, 98, 1813–1819.
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X. (2010). Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm, 394, 179–185.
   PubMed Web of Science ®Google Scholar
• Ziegler D, Gries FA. (1997). Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes, 46 Suppl 2, S62–S66.
   PubMedGoogle Scholar
• Zimmermann E, Liedtke S, Muller RH, Mader K. 1999. H-NMR as a method to characterize colloidal carrier systems. Proc Int Symp Control Release Bioact Mater 26, 591–592.
   Google Scholar
• zur Mühlen A, Schwarz C, Mehnert W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm, 45, 149–155.
   PubMed Web of Science ®Google Scholar
• zur Mühlen A, zur Mühlen E, Niehus H, Mehnert W. (1996). Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res, 13, 1411–1416.
   PubMed Web of Science ®Google Scholar